ArticlePrecision chemistry2026

An Orally Available Derivative of a Specific CK2 Inhibitor for Regulating Circadian Rhythms and Acute Myeloid Leukemia.

Tsuyoshi Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.